Glaukos Corporation
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Glaukos Corporation sits in the top decile of US sponsors by registered trial count (#500 of 15,742 sponsors by registered trial count).
Glaukos Corporation: 33 sponsored US clinical trials, 11 recruiting.
Glaukos Corporation sponsors 33 registered US clinical trials on ClinicalTrials.gov, 11 of them currently recruiting, and 17 completed. 14 of these trials are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Glaucoma Open-Angle, with 4 trials.
Top-decile sponsor footprint
Glaukos Corporation ranks in the top decile of sponsors by registered trial count (#500 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
17 of 21 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
33 total, page 1 of 1
Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus
NCT07629557
Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
NCT07495852
Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus
NCT07400952
Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
NCT07400926
Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis
NCT07400965
Phase 2/Phase 3 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
NCT07075718
Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
NCT06848946
Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
NCT06066645
Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma
NCT06057051
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
NCT05966493
Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus
NCT05314738
iStent Inject New Enrollment Post-Approval Study
NCT04624698
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
NCT05119920
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia
NCT05124275
Study of Exchange of Travoprost Intraocular Implant
NCT04615403
NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular Injuries
NCT04081103
Clinical Study Comparing Two Models of a Travoprost Intraocular Implant
NCT03868124
Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
NCT03519386
Study to Evaluate the Safety and Efficacy of Epi-on Corneal Cross-linking in Eyes With Progressive Keratoconus
NCT03442751
Study Comparing Travoprost Intraocular Implants to Timolol Ophthalmic Solution
NCT02754596
Multicenter Investigation of Trabecular Micro-Bypass Stents vs. Laser Trabeculoplasty
NCT02327312
Safety and Efficacy of Corneal Collagen Cross-Linking in Eyes With Keratoconus
NCT01972854
Glaukos® iStent® Trabecular Micro-Bypass Stent System In Conjunction With Cataract Surgery Postmarket Registry
NCT01841437
Safety and Efficacy of Corneal Collagen Cross-linking Following LASIK for Treatment of Hyperopia and Hyperopic Astigmatism
NCT01893359
Post-approval Study of The Glaukos® iStent® Trabecular Micro-bypass Stent: Extended Follow-up of the Premarket Cohort
NCT01836042
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
NCT01344187
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
NCT01643226
Multicenter Study Using Glaukos® Trabecular Micro-Bypass Stent Model GTS400 Using the G2-M-IS Injector System in Conjunction With Cataract Surgery
NCT01461291
Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery
NCT01461278
GTS400 Stent Implantation in Conjunction With Cataract Surgery in Subjects With Open-angle Glaucoma
NCT01052558
Corneal Collagen Cross-Linking for Ectasia (CXL)
NCT00674661
Corneal Collagen Cross-linking for Progressive Keratoconus
NCT00647699
A Study of the Trabecular Micro-bypass Stent in Combination With Cataract Surgery in Subjects With Open Angle Glaucoma
NCT00323284
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 9 |
| Phase 3 | 12 |
| Phase 4 | 2 |
What is open in the Glaukos Corporation pipeline
11 recruiting of 33 indexed (33% open); 17 completed (52%).
Phase mix: 14 late (III/IV) vs 11 early (I/II) (balanced across stages).
Top condition: Glaucoma Open-Angle (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Glaukos Corporation: open-pipeline peers nationwide
Peers matched on 33 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
Glaukos Corporation sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 33 trials (± recruiting share)
- Aclaris Therapeutics · 33 trials · 3% recruiting
- Antonios Likourezos · 33 trials · 12% recruiting
- Baylor University · 33 trials · 15% recruiting
- Becton, Dickinson and Company · 33 trials · 3% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this Glaukos Corporation page
33 registered trials is a research-attention snapshot, not an endorsement of Glaukos Corporation or any single study.
- 11 of Glaukos Corporation's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Glaucoma Open-Angle is the condition Glaukos Corporation studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Glaucoma Open-Angle trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Glaukos Corporation pipeline card: 33 registered trials from official public datasets.Report a data error.